Last Posted: Feb 25, 2023
- Definition of Biologically Distinct Groups of Conjunctival Melanomas According to Etiological Factors and Implications for Precision Medicine.
Gardrat Sophie, et al. Cancers 2021 0 (15)
- Molecular Genetics of Conjunctival Melanoma and Prognostic Value of TERT Promoter Mutation Analysis.
van Poppelen Natasha M, et al. International journal of molecular sciences 2021 0 (11)
- Conjunctival and uveal melanoma: Survival and risk factors following orbital exenteration.
Baum Sven Holger, et al. European journal of ophthalmology 2021 0 (1) 612-619
- Genetics of Ocular Melanoma: Insights into Genetics, Inheritance and Testing.
van Poppelen Natasha M, et al. International journal of molecular sciences 2021 0 (1)
- Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patients.
Sheng Xinan, et al. The British journal of ophthalmology 2015 0 (7) 990-6
- Mutational Landscape and Outcomes of Conjunctival Melanoma in 101 Patients.
Lally Sara E, et al. Ophthalmology 2022 0 (6) 679-693
- Immunohistochemical and mutational status of telomerase reverse transcriptase in conjunctival squamous cell carcinoma.
Jayaraj Perumal, et al. Indian journal of ophthalmology 2022 3 (3) 971-975
- Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin.
Brouwer Niels J, et al. Investigative ophthalmology & visual science 2021 4 (4) 3
- PD-L1 Expression in 65 Conjunctival Melanomas and Its Association with Clinical Outcome.
Lassalle Sandra et al. International journal of molecular sciences 2020 Nov 21(23)
- Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features, and clinical outcome.
Kenawy Nihal, et al. Pigment cell & melanoma research 2019 1
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:May 30, 2023
- Content source: